Concurrent ERBB2 missense mutations D769Y and D742 N Are Novel Acquired Mechanism of Gefitinib Resistance but Responds to Gefitinib plus Pyrotinib. (June 2020) - Zhou, Yuling; Jiang, Wenjuan; Yang, Nong; Zhang, Yongchang